Normal-appearing white matter changes in multiple sclerosis: the contribution of magnetic resonance techniques

Several magnetic resonance (MR) techniques have proved to be sensitive enough to detect the subtle pathological changes that post-mortem studies showed to occur in the normal-appearing white matter (NAWM) from patients with multiple sclerosis (MS). Although these abnormalities can be detected in other neurological conditions, they seem to be more frequent and diffuse in MS. However, the contribution of NAWM changes to the diagnosis is still unclear. Their nature is also unknown and perhaps differs in different phases and clinical manifestations of the disease. Nevertheless, the extent and severity of NAWM damage seems to be relevant in causing disability and influencing the clinical evolution in MS patients. This review will summarize the present knowledge about MR-detected NAWM changes in MS and their relevance to the diagnosis and the understanding of disease evolution.

[1]  G J Barker,et al.  Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.

[2]  F. Barkhof,et al.  Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.

[3]  R. Balaban,et al.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.

[4]  C. W. Adams,et al.  Pathology of multiple sclerosis: progression of the lesion. , 1977, British medical bulletin.

[5]  R I Grossman,et al.  Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. , 1995, Radiology.

[6]  M A Horsfield,et al.  Diffusion magnetic resonance imaging in multiple sclerosis. , 1998, Journal of neurology, neurosurgery, and psychiatry.

[7]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[8]  G. Johnson,et al.  Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[9]  L. Laitinen,et al.  Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques. , 1973, European neurology.

[10]  J. Vion-Dury,et al.  A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases , 1993, Journal of the Neurological Sciences.

[11]  P. Dupont,et al.  Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis , 1997, Multiple sclerosis.

[12]  P M Matthews,et al.  Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.

[13]  Moses Rodriguez,et al.  Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.

[14]  M Filippi,et al.  Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.

[15]  J. Olesen,et al.  In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis , 1988, Magnetic resonance in medicine.

[16]  L. Kappos,et al.  Proton MRS of Gadolinium‐enhancing MS Plaques and Metabolic Changes in Normal‐Appearing White Matter , 1995, Magnetic resonance in medicine.

[17]  A. Simmons,et al.  A proton magnetic resonance spectroscopic study in ALS , 1998, Neurology.

[18]  A. Compston,et al.  Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. , 1996, Brain : a journal of neurology.

[19]  A. Thompson,et al.  Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. , 1996, Brain : a journal of neurology.

[20]  G. Comi,et al.  Resolution‐dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis , 1995, Annals of neurology.

[21]  M. Osbakken,et al.  Spin‐lattice relaxation (T1) times of cerebral white matter in multiple sclerosis , 1986, Magnetic resonance in medicine.

[22]  J A Frank,et al.  Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis , 1998, Annals of neurology.

[23]  D. MacManus,et al.  Relaxation times of apparently normal cerebral white matter in multiple sclerosis. , 1986, Acta radiologica. Supplementum.

[24]  P M Matthews,et al.  Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques , 1992, Annals of neurology.

[25]  P M Matthews,et al.  Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. , 1996, Brain : a journal of neurology.

[26]  P M Matthews,et al.  Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.

[27]  G. Barker,et al.  Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis , 1999, Journal of the Neurological Sciences.

[28]  A. Thompson,et al.  Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.

[29]  V. Haughton,et al.  Quantitative MR in the diagnosis of multiple sclerosis , 1992, Magnetic resonance in medicine.

[30]  R. Grossman,et al.  Magnetization transfer imaging of periventricular hyperintense white matter in the elderly. , 1995, AJNR. American journal of neuroradiology.

[31]  Y. Kinosada,et al.  Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements. , 1997, AJNR. American journal of neuroradiology.

[32]  G. Barker,et al.  Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.

[33]  Massimo Filippi,et al.  Brain and spinal cord MR in benign multiple sclerosis: a follow-up study , 1996, Journal of the Neurological Sciences.

[34]  D Gounot,et al.  In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. , 1991, Magnetic resonance imaging.

[35]  J K Udupa,et al.  Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.

[36]  W. Mcdonald,et al.  The pathological evolution of multiple sclerosis , 1992, Neuropathology and applied neurobiology.

[37]  M Filippi,et al.  Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI , 1999, Neurology.

[38]  M Rovaris,et al.  Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis , 1998, Neurology.

[39]  F. Barkhof,et al.  Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.

[40]  J. Dartigues,et al.  Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. , 1997, AJNR. American journal of neuroradiology.

[41]  I. Allen,et al.  A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.

[42]  A. Thompson,et al.  Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.

[43]  G. Fein,et al.  Biochemical alterations in multiple sclerosis lesions and normal‐appearing white matter detected by in vivo 31P and 1H spectroscopic imaging , 1994, Annals of neurology.

[44]  G J Barker,et al.  Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: Relationship to clinical parameters , 1996, Journal of magnetic resonance imaging : JMRI.

[45]  M W Weiner,et al.  1H MRSI of normal appearing white matter in multiple sclerosis , 1997, Multiple sclerosis.

[46]  C P Langlotz,et al.  MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. , 1998, AJNR. American journal of neuroradiology.

[47]  H. Bruhn,et al.  Multiple sclerosis in children: Cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo , 1992, Annals of neurology.

[48]  C. Thomsen,et al.  Increased water self‐diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis , 1993, Acta neurologica Scandinavica.

[49]  M Filippi,et al.  Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis. , 1999, AJNR. American journal of neuroradiology.

[50]  A J Thompson,et al.  PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS , 1997 .

[51]  R H Edwards,et al.  Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. , 1994, Magnetic resonance imaging.

[52]  Marco Rovaris,et al.  Brain MRI correlates of magnetization transfer imaging metrics in patients with multiple sclerosis , 1999, Journal of the Neurological Sciences.

[53]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[54]  A. Baert,et al.  Human brain proton localized NMR spectroscopy in multiple sclerosis , 1991, Magnetic resonance in medicine.

[55]  R. Kamman,et al.  In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis. , 1992, Archives of neurology.

[56]  R I Grossman,et al.  Quantitative volumetric magnetization transfer analysis in multiple sclerosis: Estimation of macroscopic and microscopic disease burden , 1996, Magnetic resonance in medicine.

[57]  H. Tobi,et al.  Correlating MRI and clinical disease activity in multiple sclerosis , 1995, Neurology.

[58]  R E Lenkinski,et al.  Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis , 1994, Magnetic resonance in medicine.

[59]  M Filippi,et al.  Magnetization transfer imaging of patients with definite MS and negative conventional MRI , 1999, Neurology.

[60]  L. Deecke,et al.  Changes within the "normal" cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[61]  G. Barker,et al.  The transverse magnetisation decay characteristics of longstanding lesions and normal-appearing white matter in multiple sclerosis , 1997, Journal of Neurology.

[62]  G Johnson,et al.  Precise relaxation time measurements of normal‐appearing white matter in inflammatory central nervous system disease , 1989, Magnetic resonance in medicine.

[63]  G. Comi,et al.  Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium , 1998, Neurology.

[64]  David H. Miller,et al.  Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance , 1996, Magnetic resonance in medicine.

[65]  E. Cabanis,et al.  In vivo localized NMR proton spectroscopy of normal appearing white matter in patients with multiple sclerosis. , 1996, Journal of neuroradiology. Journal de neuroradiologie.

[66]  M. Filippi,et al.  A magnetization transfer study of white matter in siblings of multiple sclerosis patients , 1997, Journal of the Neurological Sciences.

[67]  J K Udupa,et al.  Correlation of volumetric magnetization transfer imaging with clinical data in MS , 1998, Neurology.

[68]  J S Wolinsky,et al.  Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis , 1998, Annals of neurology.

[69]  F. Barkhof,et al.  Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.

[70]  G J Barker,et al.  Serial magnetization transfer imaging to characterize the early evolution of new MS lesions , 1998, Neurology.

[71]  D Origgi,et al.  Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. , 1998, AJNR. American journal of neuroradiology.

[72]  M Filippi,et al.  A magnetization transfer histogram study of normal-appearing brain tissue in MS , 2000, Neurology.

[73]  P M Matthews,et al.  Axonal dysfunction and disability in a relapse of multiple sclerosis: Longitudinal study of a patient , 1997, Neurology.

[74]  G. Barker,et al.  1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.

[75]  R E Lenkinski,et al.  Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease. , 1996, AJNR. American journal of neuroradiology.

[76]  R I Grossman,et al.  Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. , 1992, Radiology.

[77]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.

[78]  M Filippi,et al.  A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis , 1995, Neurology.

[79]  M Filippi,et al.  The role of non-conventional magnetic resonance techniques in monitoring evolution of multiple sclerosis. , 1998, Journal of neurology, neurosurgery, and psychiatry.